Infectious Disease Market by Product, End-user, and Geography - Forecast and Analysis 2023-2027

Published: Nov 2022 Pages: 165 SKU: IRTNTR71174

Infectious Disease Market Analysis Report 2023-2027: 

The infectious disease market size is estimated to grow at a CAGR of 12.49% between 2022 and 2027. The infectious disease market size is forecast to increase by USD 104.81 billion. This report covers several market vendors, including Rad Laboratories Inc., Danaher Corp., F. Hoffmann La Roche Ltd., Genetic Signatures Ltd., Grifols SA, Hologic Inc., Meridian Bioscience Inc., Meril Life Sciences Pvt. Ltd., OraSure Technologies Inc., PerkinElmer Inc., QIAGEN NV, Siemens AG, Sysmex Corp., Trinity Biotech Plc, Abbott Laboratories, Becton Dickinson and Co., bioMerieux SA, DiaSorin SpA, Quidel Corp., and Thermo Fisher Scientific Inc. The growth of the market depends on several factors, including the rising demand from the oil and gas industry, the increasing number of applications in food and beverages, and advancements in carbon capturing and storage technologies. 

What will be the size of the Infectious Disease Market During the Forecast Period?

To learn more about this report, View Report Sample

COVID-19 Analysis

  • This market report forecasts the contribution of all the segments to the growth of the market. In addition, we have included the COVID-19 impact and the recovery strategies for each segment. The outbreak of COVID-19 led to a surge in demand for infectious disease drugs in North America. In 2020, the outbreak of COVID-19 affected the economies of all countries in North America, especially the US.
  • Most pharmaceutical operations were directed toward developing vaccines and therapeutics for COVID-19, which fostered the growth of the market in 2020 and mid-2021 to a substantial extent. Since the beginning of 2021, lockdown restrictions in the region were somewhat relaxed, which helped the restoration of the pharmaceutical supply chain in the region. The rising prevalence of infectious diseases in the region will drive market growth during the forecast period.

Who are the Major Infectious Disease Market Vendors?

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

bio-rad.com - The company offers therapeutics for infectious diseases that help in earlier diagnosis, appropriate therapy selection, personalized care, and infectious disease monitoring.

What is the Fastest-Growing Segment in the Infectious Disease Market?

The market share growth by the drugs segment will be significant during the forecast period. As per the WHO 2019 Global Tuberculosis Report, the total number of TB-infected patients across the world was estimated to be 6.3 million. The figure fell to 4.9 million in 2020. Fewer cases of TB were notified in 2020 owing to the outbreak of the COVID-19 pandemic, which, in turn, led to over half a million deaths from the disease globally in 2020. Thus, the rising number of cases of infectious diseases is expected to increase the demand for respective drugs, thereby driving the growth of the market during the forecast period.

Get a glance at the market contribution of various segments View PDF Sample

The Drugs segment showed a gradual increase in market share with USD 41.48 billion in 2017 and continued to grow by 2021. The drugs used for the treatment of infectious diseases act either by inhibiting the spread of an infectious agent or by destroying the infectious agent. Bacteria such as Staphylococcus, Streptococcus, Pseudomonas, E. coli, Clostridium difficile, and Listeria are the most common causes of infections leading to skin infections, tonsillitis, cancer, diarrhea, abdominal pain, and fever. Infections caused by viruses are the common cold, flu, chickenpox, COVID-19, and Ebola. Fungal infections such as thrush affect the oral cavities, while protozoal infections can cause intestinal infections. Hence, anti-infective drugs are required to destroy infectious agents that cause various diseases in human beings, including tuberculosis (TB), sepsis, and smallpox. Furthermore, our report provides a brief analysis of the historical and forecast market share and their segments along with the reasons for growth from 2017 to 2027.

Which are the Key Regions for the Infectious Disease Market?

For more insights on the market share of various regions View PDF Sample now!

North America is projected to contribute 42% of market growth by 2027. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

The market in North America is led by the US because of the presence of top players such as Gilead Sciences, Inc., Johnson & Johnson, Pfizer, and AbbVie, which generate high revenue from their leading drugs. In addition, these vendors invest in marketing and patient awareness initiatives. The US is one of the major contributors to the market in the region. This is because of the presence of top players, including Aridis Pharmaceuticals, Entasis Therapeutics, and Merck. The market is expected to have accelerated growth momentum during the forecast period. The major factors driving the market growth include the development and launch of drugs for the treatment of infectious diseases and the proper treatment of the patient population. 

Infectious Disease Market: Key Drivers, Trends, Challenges, and Customer Landscape

The increasing prevalence of infectious diseases is notably driving the market growth, although factors such as the adverse effects of anti-infective drugs may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Infectious Disease Market Driver

  • The increasing prevalence of infectious diseases is the key factor driving the market growth. There has been an increase in the prevalence of infectious diseases. Globally, infectious disease outbreaks have increased due to changing lifestyles, which result in reduced immunity. The pattern of infectious disease incidence has also been changing with the evolution of drug-resistant pathogens. HIV/AIDS is a leading cause of death in many countries.
  • According to the CDC, in 2019, only 370 new cases of meningococcal disease were reported in the US. Globally, the incidence and prevalence of infectious diseases have increased due to climate change and its consequences. This is expected to be a major driver for market growth during the forecast period.

Significant Infectious Disease Market Trends

  • The development of novel drugs will fuel market growth. There has been an increase in the R&D of novel drugs for the treatment of infectious diseases. For instance, researchers at the Indian Institute of Science have discovered a new drug combination that promises better outcomes in treating tuberculosis. In patients with tuberculosis, the bacterium continues to develop resistance against certain old drugs.
  • According to researchers, the new drug called pranlukast can kill the tuberculosis bacterium as well as weaken its survival strategies within cells. This discovery will provide an opportunity to use this novel drug combination in tuberculosis therapeutics. Researchers are searching for new tuberculosis drugs to complement bedaquiline and expand the treatment options available to healthcare professionals worldwide. Such developments are expected to have a positive impact on the growth of the market during the forecast period.

Major Infectious Disease Market Challenge

  • The adverse effects of anti-infective drugs are a major challenge to market growth. Multiple drugs are being approved by the US FDA and are being indicated for the treatment of different infectious diseases. However, these drugs are associated with adverse effects. The potential adverse effects of anti-infective drugs are bone marrow growth suppression, anaphylaxis, nephrotoxicity, and ototoxicity.
  • For instance, PENTAX is an anti-infective drug that is used to treat pneumonia caused by Pneumocystis carinii. However, the drug has some side effects, including breathing problems, unusual bleeding or bruising; chest pain; and a fast, irregular heart rate. The adverse effects of anti-infective drugs can reduce patient compliance, thereby leading to a decline in the growth of the market.

Key Infectious Disease Market Customer Landscape

The infectious disease market analysis report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Infectious Disease Market Customer Landscape

Segment Overview

The infectious disease market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • Product Outlook (USD Million, 2017 - 2027)
    • Drugs
    • Vaccines
  • End-user Outlook (USD Million, 2017 - 2027)
    • Hospital
    • Multispecialty clinic
    • Others
  • Region Outlook (USD Million, 2017 - 2027)
    • North America
      • The U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Rest of Europe
    • APAC
      • China
      • India
    • Middle East & Africa
      • Saudi Arabia
      • South Africa
      • Rest of the Middle East & Africa

Infectious Disease Market Scope

Report Coverage

Details

Page number

165

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 12.49%

Market growth 2023-2027

$ 104.81 billion

Market structure

Fragmented

YoY growth 2022-2023(%)

11.16

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 42%

Key countries

US, Germany, UK, China, and Japan

Competitive landscape

 Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Bio Rad Laboratories Inc., Danaher Corp., F. Hoffmann La Roche Ltd., Genetic Signatures Ltd., Grifols SA, Hologic Inc., Meridian Bioscience Inc., Meril Life Sciences Pvt. Ltd., OraSure Technologies Inc., PerkinElmer Inc., QIAGEN NV, Siemens AG, Sysmex Corp., Trinity Biotech Plc, Abbott Laboratories, Becton Dickinson and Co., bioMerieux SA, DiaSorin SpA, Quidel Corp., and Thermo Fisher Scientific Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Get access to Report Sample PDF !

What are the Key Data Covered in this Infectious Disease Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the infectious disease market between 2023 and 2027
  • Precise estimation of the size of the infectious disease market size and its contribution of the market in focus on the parent market
  • Accurate predictions about upcoming trends and changes in consumer behaviour
  • Growth of the market industry across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information about vendors
  • Comprehensive analysis of factors that will challenge the growth of infectious disease market vendors

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global infectious disease market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on Global infectious disease market 2017 - 2021 ($ billion)
    • 4.2 Product Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ billion)
    • 4.3 End-user Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – End-user Segment 2017 - 2021 ($ billion)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ billion)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ billion)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Product

    • 6.1 Market segments
      • Exhibit 30: Chart on Product - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
    • 6.2 Comparison by Product
      • Exhibit 32: Chart on Comparison by Product
      • Exhibit 33: Data Table on Comparison by Product
    • 6.3 Drugs - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Drugs - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 35: Data Table on Drugs - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 36: Chart on Drugs - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Drugs - Year-over-year growth 2022-2027 (%)
    • 6.4 Vaccines - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Vaccines - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 39: Data Table on Vaccines - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 40: Chart on Vaccines - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Vaccines - Year-over-year growth 2022-2027 (%)
    • 6.5 Market opportunity by Product
      • Exhibit 42: Market opportunity by Product ($ billion)

    7 Market Segmentation by End-user

    • 7.1 Market segments
      • Exhibit 43: Chart on End-user - Market share 2022-2027 (%)
      • Exhibit 44: Data Table on End-user - Market share 2022-2027 (%)
    • 7.2 Comparison by End-user
      • Exhibit 45: Chart on Comparison by End-user
      • Exhibit 46: Data Table on Comparison by End-user
    • 7.3 Hospital - Market size and forecast 2022-2027
      • Exhibit 47: Chart on Hospital - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 48: Data Table on Hospital - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 49: Chart on Hospital - Year-over-year growth 2022-2027 (%)
      • Exhibit 50: Data Table on Hospital - Year-over-year growth 2022-2027 (%)
    • 7.4 Multispecialty clinic - Market size and forecast 2022-2027
      • Exhibit 51: Chart on Multispecialty clinic - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 52: Data Table on Multispecialty clinic - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 53: Chart on Multispecialty clinic - Year-over-year growth 2022-2027 (%)
      • Exhibit 54: Data Table on Multispecialty clinic - Year-over-year growth 2022-2027 (%)
    • 7.5 Others - Market size and forecast 2022-2027
      • Exhibit 55: Chart on Others - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 56: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 57: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 58: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 7.6 Market opportunity by End-user
      • Exhibit 59: Market opportunity by End-user ($ billion)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 61: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 62: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 63: Chart on Geographic comparison
      • Exhibit 64: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 Germany - Market size and forecast 2022-2027
      • Exhibit 85: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 86: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 87: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.9 China - Market size and forecast 2022-2027
      • Exhibit 89: Chart on China - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 90: Data Table on China - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 91: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 92: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.10 UK - Market size and forecast 2022-2027
      • Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.11 Japan - Market size and forecast 2022-2027
      • Exhibit 97: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 98: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
      • Exhibit 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 101: Market opportunity by geography ($ billion)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 102: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 104: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 105: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 106: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 107: Matrix on vendor position and classification
            • 12.3 Abbott Laboratories
              • Exhibit 108: Abbott Laboratories - Overview
              • Exhibit 109: Abbott Laboratories - Business segments
              • Exhibit 110: Abbott Laboratories - Key news
              • Exhibit 111: Abbott Laboratories - Key offerings
              • Exhibit 112: Abbott Laboratories - Segment focus
            • 12.4 Becton Dickinson and Co.
              • Exhibit 113: Becton Dickinson and Co. - Overview
              • Exhibit 114: Becton Dickinson and Co. - Business segments
              • Exhibit 115: Becton Dickinson and Co. - Key news
              • Exhibit 116: Becton Dickinson and Co. - Key offerings
              • Exhibit 117: Becton Dickinson and Co. - Segment focus
            • 12.5 Bio Rad Laboratories Inc.
              • Exhibit 118: Bio Rad Laboratories Inc. - Overview
              • Exhibit 119: Bio Rad Laboratories Inc. - Business segments
              • Exhibit 120: Bio Rad Laboratories Inc. - Key news
              • Exhibit 121: Bio Rad Laboratories Inc. - Key offerings
              • Exhibit 122: Bio Rad Laboratories Inc. - Segment focus
            • 12.6 bioMerieux SA
              • Exhibit 123: bioMerieux SA - Overview
              • Exhibit 124: bioMerieux SA - Product / Service
              • Exhibit 125: bioMerieux SA - Key offerings
            • 12.7 Danaher Corp.
              • Exhibit 126: Danaher Corp. - Overview
              • Exhibit 127: Danaher Corp. - Business segments
              • Exhibit 128: Danaher Corp. - Key news
              • Exhibit 129: Danaher Corp. - Key offerings
              • Exhibit 130: Danaher Corp. - Segment focus
            • 12.8 DiaSorin SpA
              • Exhibit 131: DiaSorin SpA - Overview
              • Exhibit 132: DiaSorin SpA - Business segments
              • Exhibit 133: DiaSorin SpA - Key news
              • Exhibit 134: DiaSorin SpA - Key offerings
              • Exhibit 135: DiaSorin SpA - Segment focus
            • 12.9 F. Hoffmann La Roche Ltd.
              • Exhibit 136: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 137: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 138: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 139: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 140: F. Hoffmann La Roche Ltd. - Segment focus
            • 12.10 Meridian Bioscience Inc.
              • Exhibit 141: Meridian Bioscience Inc. - Overview
              • Exhibit 142: Meridian Bioscience Inc. - Business segments
              • Exhibit 143: Meridian Bioscience Inc. - Key offerings
              • Exhibit 144: Meridian Bioscience Inc. - Segment focus
            • 12.11 OraSure Technologies Inc.
              • Exhibit 145: OraSure Technologies Inc. - Overview
              • Exhibit 146: OraSure Technologies Inc. - Business segments
              • Exhibit 147: OraSure Technologies Inc. - Key offerings
              • Exhibit 148: OraSure Technologies Inc. - Segment focus
            • 12.12 PerkinElmer Inc.
              • Exhibit 149: PerkinElmer Inc. - Overview
              • Exhibit 150: PerkinElmer Inc. - Business segments
              • Exhibit 151: PerkinElmer Inc. - Key news
              • Exhibit 152: PerkinElmer Inc. - Key offerings
              • Exhibit 153: PerkinElmer Inc. - Segment focus
            • 12.13 QIAGEN NV
              • Exhibit 154: QIAGEN NV - Overview
              • Exhibit 155: QIAGEN NV - Product / Service
              • Exhibit 156: QIAGEN NV - Key news
              • Exhibit 157: QIAGEN NV - Key offerings
            • 12.14 Quidel Corp.
              • Exhibit 158: Quidel Corp. - Overview
              • Exhibit 159: Quidel Corp. - Product / Service
              • Exhibit 160: Quidel Corp. - Key offerings
            • 12.15 Siemens AG
              • Exhibit 161: Siemens AG - Overview
              • Exhibit 162: Siemens AG - Business segments
              • Exhibit 163: Siemens AG - Key news
              • Exhibit 164: Siemens AG - Key offerings
              • Exhibit 165: Siemens AG - Segment focus
            • 12.16 Thermo Fisher Scientific Inc.
              • Exhibit 166: Thermo Fisher Scientific Inc. - Overview
              • Exhibit 167: Thermo Fisher Scientific Inc. - Business segments
              • Exhibit 168: Thermo Fisher Scientific Inc. - Key news
              • Exhibit 169: Thermo Fisher Scientific Inc. - Key offerings
              • Exhibit 170: Thermo Fisher Scientific Inc. - Segment focus
            • 12.17 Trinity Biotech Plc
              • Exhibit 171: Trinity Biotech Plc - Overview
              • Exhibit 172: Trinity Biotech Plc - Product / Service
              • Exhibit 173: Trinity Biotech Plc - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 174: Inclusions checklist
                • Exhibit 175: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 176: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 177: Research methodology
                • Exhibit 178: Validation techniques employed for market sizing
                • Exhibit 179: Information sources
              • 13.5 List of abbreviations
                • Exhibit 180: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              infectious disease market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis